# Dietary Sources of Glycine Betaine and Proline Betaine in Plant Foods and Their Potential Biological Relevance in Human Nutrition

**Authors:** Bruna Laratta, Rosanna Squitti, Domenico Cautela

PMC · DOI: 10.3390/foods15040759 · Foods · 2026-02-19

## TL;DR

This study identifies plant-based sources of glycine betaine and proline betaine and explores their potential roles in human nutrition and metabolism.

## Contribution

The study combines targeted quantification and in silico analyses to characterize dietary betaines and their biological relevance.

## Key findings

- Glycine betaine is abundant in leafy vegetables and cereal flours, while proline betaine is enriched in citrus fruits.
- In silico analyses show similar pharmacokinetic profiles for both betaines but distinct metabolic associations.
- Betaines are proposed as biomarkers for dietary intake and metabolic status.

## Abstract

Betaines are natural nitrogen-containing compounds widely distributed in plant-derived foods and animal tissues, where they function primarily as osmolytes, chaperons, and methyl donors. As such, they have attracted increasing interest as dietary components and metabolic biomarkers in human nutrition. This study provides a comparative characterization of glycine betaine (GlyBet) and proline betaine (ProBet) by combining targeted LC–MS quantification in a representative selection of plant-based foods with complementary in silico analyses and integration of dietary intake estimates derived from published nutritional and metabolomic studies, together with human metabolomic data. A validated HPLC–ESI–MS method was applied to quantify GlyBet and ProBet across cereals, pseudocereals, vegetables, and fruits. GlyBet was found to be predominantly abundant in leafy vegetables and in several cereal and pseudocereal flours, whereas ProBet was highly enriched in citrus fruits, particularly bergamot, chinotto, and bitter orange. In silico ADMET predictions were used to provide a qualitative and comparative description of the pharmacokinetic and safety-related properties of the two betaines, indicating broadly similar hydrophilic profiles with modest differences in solubility, clearance, and predicted skin sensitization. Similarity-based target prediction analyses, used in an exploratory framework, suggest distinct contextual tendencies for the two betaines. GlyBet is primarily associated with pathways related to one-carbon metabolism and cellular stress responses, whereas ProBet shows a closer contextual association with signaling-related processes. By integrating experimental data, computational analyses, and human metabolomic information, this work supports the interpretation of betaines as biomarkers of dietary intake and systemic metabolic status.

## Linked entities

- **Chemicals:** glycine betaine (PubChem CID 247), proline betaine (PubChem CID 115244)

## Full-text entities

- **Genes:** PGP (phosphoglycolate phosphatase) [NCBI Gene 283871] {aka AUM, G3PP, PGPase}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, BBOX1 (gamma-butyrobetaine hydroxylase 1) [NCBI Gene 8424] {aka BBH, BBOX, G-BBH, gamma-BBH}, COMT (catechol-O-methyltransferase) [NCBI Gene 1312] {aka HEL-S-98n}, CYP2C19 (cytochrome P450 family 2 subfamily C member 19) [NCBI Gene 1557] {aka CPCJ, CYP2C, CYPIIC17, CYPIIC19, P450C2C, P450IIC19}, CTSD (cathepsin D) [NCBI Gene 1509] {aka CLN10, CPSD, HEL-S-130P}, SLC22A4 (solute carrier family 22 member 4) [NCBI Gene 6583] {aka DFNB60, ETTh, OCTN1}, PPIG (peptidylprolyl isomerase G) [NCBI Gene 9360] {aka CARS-Cyp, CYP, SCAF10, SRCyp}, SLC22A2 (solute carrier family 22 member 2) [NCBI Gene 6582] {aka OCT2}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) [NCBI Gene 1565] {aka CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2}, CYP4F3 (cytochrome P450 family 4 subfamily F member 3) [NCBI Gene 4051] {aka CPF3, CYP4F, CYPIVF3, LTB4H}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, CYP3A4 (cytochrome P450 family 3 subfamily A member 4) [NCBI Gene 1576] {aka CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4}, CYP2C9 (cytochrome P450 family 2 subfamily C member 9) [NCBI Gene 1559] {aka CPC9, CYP2C, CYP2C10, CYPIIC9, P450-2C9, P450IIC9}, CYP1A2 (cytochrome P450 family 1 subfamily A member 2) [NCBI Gene 1544] {aka CP12, CYPIA2, P3-450, P450(PA)}, SLC22A5 (solute carrier family 22 member 5) [NCBI Gene 6584] {aka CDSP, OCTN2}, BHMT (betaine--homocysteine S-methyltransferase) [NCBI Gene 635] {aka BHMT1, HEL-S-61p}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}
- **Diseases:** Metabolic disorders (MESH:D008659), fetal (MESH:D005315), hepatic steatosis (MESH:D005234), non-alcoholic steatohepatitis (MESH:D005235), liver cirrhosis (MESH:D008103), lysosomal dysfunction (MESH:D016464), preeclampsia (MESH:D011225), schizophrenia (MESH:D012559), hypermethioninemia (MESH:C564683), NAFLD (MESH:D065626), neuropsychiatric conditions (MESH:D001523), chromosomal abnormalities (MESH:D002869), hepatic dysfunction (MESH:D008107), inflammation (MESH:D007249), injury to (MESH:D014947), metabolic and renal disturbances (MESH:D024821), cirrhosis (MESH:D005355), Renal conditions (MESH:D007674), heart failure (MESH:D006333), Toxicity (MESH:D064420), Cardiovascular diseases (MESH:D002318), uremic (MESH:D006463), chronic renal failure (MESH:D007676)
- **Chemicals:** AMES (MESH:C017501), alkaloids (MESH:D000470), thiazole (MESH:D013844), S-adenosylmethionine (MESH:D012436), quaternary ammonium compounds (MESH:D000644), water (MESH:D014867), Fu (MESH:D005472), carbon (MESH:D002244), ProBet (MESH:C003342), nitrogen (MESH:D009584), salts (MESH:D012492), Formic acid (MESH:C030544), acid (MESH:D000143), ergothioneine (MESH:D004880), methionine (MESH:D008715), proline (MESH:D011392), flavonoids (MESH:D005419), hydrogen (MESH:D006859), polyphenols (MESH:D059808), phosphatidylcholine (MESH:D010713), alpha-amino acids (MESH:D000596), homocysteine (MESH:D006710), Betaines (MESH:D001622), carnitine (MESH:D002331), 4-butyrobetaine (-), bergamot (MESH:C068336)
- **Species:** Chenopodium quinoa (quinoa, species) [taxon 63459], Panicum miliaceum (broomcorn millet, species) [taxon 4540], Spinacia oleracea (spinach, species) [taxon 3562], Fagopyrum esculentum (common buckwheat, species) [taxon 3617], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Brassica oleracea var. botrytis (cauliflower, varietas) [taxon 3715], Homo sapiens (human, species) [taxon 9606], Citrus x aurantium (bitter orange, species) [taxon 43166], Ipomoea batatas (batate, species) [taxon 4120]
- **Mutations:** X15R
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940802/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12940802/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940802/full.md

---
Source: https://tomesphere.com/paper/PMC12940802